Bone marrow transplantation for non-malignant diseases using treosulfan-based conditioning-Reference-Cited by-同舟云学术

Bone marrow transplantation for non-malignant diseases using treosulfan-based conditioning

Published:2014-10-04 Issue:2 Volume:62 Page:299-304
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Dinur-Schejter Yael¹,Krauss Aviva C.²,Erlich Odeya¹,Gorelik Natan¹,Yahel Anat²,Porat Iris³,Weintraub Michael¹,Stein Jerry²,Zaidman Irina³,Stepensky Polina¹

Affiliation:

1. Department of Pediatric Hematology-Oncology and Bone Marrow Transplantation; Hadassah Hebrew University Medical Center; Jerusalem Israel

2. Department of Pediatric Hematology Oncology and BMT Unit; Schneider Children's Medical Center of Israel; Petah-Tikva Israel

3. Department of Pediatric Hematology Oncology; Meyer Children's Hospital; Rambam Health Care Campus; Haifa Israel

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference12 articles.

1. Reduced intensity transplantation for primary immunodeficiency disorders. Immunol Allergy;Veys;Clin North Am,2010

2. Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience;Slatter;Blood,2011

3. Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience;Beier;Bone Marrow Transplant,2012

4. Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major;Bernardo;Br J Haematol,2008

5. Treosulfan-containing regimens achieve high rates of engraftment associated with low transplant morbidity and mortality in children with non-malignant disease and significant co-morbidities;Greystoke;Br J Haematol,2008

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes from hematopoietic stem cell transplantation following treosulfan‐based conditioning: A clinical and pharmacokinetic analysis;Pediatric Transplantation;2024-05-20

2. Busulfan-Based and Treosulfan-Based Myeloablative Conditioning for Allogeneic Transplantation in Children with Thalassemia Major: a Single-Center Experience From Southern Turkey;Experimental and Clinical Transplantation;2023-11

3. Personalized hematopoietic stem cell transplantation for inborn errors of immunity;Frontiers in Immunology;2023-04-05

4. Hematopoietic stem cell transplantation in a patient with activated phosphoinositide 3‑kinase δ syndrome: A case report and literature review;Central European Journal of Immunology;2023

5. Advances in the treatment of severe combined immunodeficiency;Clinical Immunology;2022-09